Angel News
Angel News
Angel News

Back to Homepage

19th April 2018

Zelluna Immunotherapy appoints Arjan Roozen as CTO

Zelluna Immunotherapy, the biotechnology company specializing in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, has announced the appointment of Arjan Roozen as chief technology officer (CTO). 

...

Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage